SEC Filing Summary: Zapata Corporation (10-Q)
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Zapata Corporation for the period ended June 30, 1995. The Company is in a significant transitional phase, actively divesting its energy-related assets (natural gas compression, oil and gas) to pivot toward food-related businesses. Notably, the Company decided to retain its Marine Protein operations, reclassifying them from discontinued to continuing operations, and recently acquired a 31% stake in Envirodyne Industries, Inc., a food packaging supplier.
Key Financial Metrics
| Metric | Three Months Ended June 30, 1995 | Nine Months Ended June 30, 1995 |
|---|---|---|
| Revenues | $36.7 million | $126.6 million |
| Net Income (Loss) | $1.8 million | $5.4 million |
| Net Income to Common Stockholders | $1.8 million | $5.4 million |
| Operating Loss (Continuing Ops) | $(11.2) million | $(11.5) million |
| Cash Flow from Operating Activities | N/A | $5.7 million |
| Cash and Cash Equivalents (End of Period) | $1.9 million | $1.9 million |
| Long-Term Debt | $34.4 million | $34.4 million |
| Working Capital | $100.6 million | $100.6 million |
Material Changes vs. Prior Period
- Revenue Decline: Revenues dropped 43% year-over-year for the quarter ($36.7M vs. $64.7M) and 34% for the nine-month period ($126.6M vs. $192.1M). This is primarily due to reduced natural gas trading activity and the reclassification of the Natural Gas Compression division to discontinued operations.
- Profitability Improvement: Net income turned positive ($1.8M) compared to a net loss of $9.6M in the prior year quarter. This improvement is largely driven by an $8.9 million reversal of a reserve for loss on the disposition of Marine Protein operations (which were retained) and income from discontinued operations.
- Asset Impairment: The Company recorded a $12.6 million pretax provision for asset impairment in Marine Protein operations due to the adoption of SFAS 121, reducing assets to fair market value.
- Cash Flow: Operating cash flow improved significantly to a positive $5.7 million for the nine-month period, compared to a $12.1 million cash outflow in the prior year.
Guidance, Outlook, and Risks
- Strategic Pivot: Management is transforming the company away from energy into food-related businesses. The acquisition of 31% of Envirodyne Industries for $18.8 million (paid via promissory note) is the first major step. Future mergers or acquisitions in this sector are being evaluated.
- Divestitures:
- Natural Gas Compression: Agreed to sell assets to Enterra Corporation for $130 million. The deal is subject to definitive agreements and government approvals; completion is not assured.
- Oil and Gas: Completed the sale of remaining U.S. offshore properties in July 1995. Plans to retain Bolivian operations.
- Capital Allocation: The Board authorized the repurchase of up to 7.5 million shares of common stock. In April 1995, 2.25 million shares were repurchased.
- Liquidity: The Company has $1.9 million in cash and a $15.0 million bank credit facility arranged for its protein subsidiary. Mandatory debt payments for the next 12 months total $8.4 million.
- Risks: The sale of the natural gas compression division is not guaranteed. The Marine Protein division faces operational challenges, including a 22% lower fish catch due to weather and a significant asset write-down.
Investor Verification Checklist
- Verify the status and closing conditions of the $130 million sale of the Natural Gas Compression division to Enterra Corporation.
- Confirm the terms and interest rate of the $18.8 million promissory note issued for the Envirodyne Industries acquisition.
- Monitor the operational recovery of the Marine Protein division following the $12.6 million asset impairment and weather-related catch declines.
- Review the Company's progress in executing the authorized share repurchase program (up to 7.5 million shares).
- Assess the sustainability of the $15.0 million credit facility for Zapata Protein, Inc. given the division's recent operating losses.